
Dyne Therapeutics, Inc.
USD22.42
+1.16 (+5.44%)
CEO
John G. Cox
IPO Date
2020-09-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$21.28
Prev. Close
$21.26
Day Low
$21.18
Day High
$22.49
52W Low
$8.06
52W High
$25.00
Market Cap
$3.71B
Volume
0.47M
| 3 Mar 2026 |
| Morgan Stanley |
| Overweight |
| Overweight |
| maintain |
| 3 Mar 2026 | Chardan Capital | Buy | Buy | maintain |
| 3 Mar 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 20 Jan 2026 | JP Morgan | Neutral | Neutral | maintain |
| 15 Dec 2025 | Evercore ISI Group | Outperform | Outperform | maintain |
| 11 Dec 2025 | Stifel | Buy | Buy | maintain |
| 10 Dec 2025 | Oppenheimer | Perform | Outperform | upgrade |